Uniting Dermatology and Oncology During Breast Cancer Awareness Month

Each October, Breast Cancer Awareness Month reminds us of the critical role early detection and multidisciplinary care play in improving patient outcomes. Although breast cancer is most often associated with breast surgeons and oncologists, dermatologists also have a unique role in the continuum of care. Patients may first present to dermatologists with skin-related signs that could represent breast cancer or its treatments, highlighting why dermatology is an essential voice in these conversations.

This special edition of Dermatology Times is dedicated to exploring the important intersection of dermatology and breast oncology. From recognizing dermatologic manifestations of breast cancer—such as cutaneous metastases or Paget disease—to managing the adverse skin effects of treatments, dermatologists can be on the front lines of detection, diagnosis, and supportive care.

Equally important is the collaboration between dermatologists and oncologists. By working together, each specialist ensures that patients benefit from comprehensive, coordinated treatment plans that address not only survival but also quality of life. Dermatologists’ expertise in managing therapy-related toxicities can help patients remain adherent to lifesaving treatments, and their skills can support earlier detection on the skin.

Dermatology Times believes it is vital to highlight these connections during Breast Cancer Awareness Month. By fostering dialogue across specialties, dermatologists and oncologists can better serve patients and contribute to the shared mission of advancing cancer care. We invite you to explore the perspectives, research, and clinical insights presented in this issue as we honor the importance of collaboration in breast cancer management.

We also invite you to visit DermatologyTimes.com on October 13 for a special digital supplement featuring breast cancer research from numerous MJH Life Sciences brands.

As always, Dermatology Times delivers the most up-to-date clinical content, from innovative studies and FDA approvals to exclusive interviews and expert perspectives. Stay informed with the latest data by subscribing to Dermatology Times’ e-newsletters and following us on Facebook, LinkedIn, and X.